Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11926
Cineverse
CNVS
$57.1M
| $77.6K | ﹤0.01% |
16,237
-6,206
| -28% | -$20.6K |
|
|
CLYM
11927
Climb Bio
CLYM
$924M
| $77.3K | ﹤0.01% |
62,358
+19,852
| +47% | +$24.7K |
|
|
OCCI
11928
OFS Credit Co
OCCI
$77.2M
| $77.3K | ﹤0.01% |
+12,402
| New | +$78.7K |
|
11929
Orion Energy Systems
OESX
$102M
| $77.2K | ﹤0.01% |
12,655
+4,765
| +60% | +$32.3K |
|
|
CLPR
11930
Clipper Realty
CLPR
$54.3M
| $77K | ﹤0.01% |
20,990
-17,235
| -45% | -$65.9K |
|
11931
Sphere 3D
ANY
$21M
| $76.8K | ﹤0.01% |
13,008
+9,247
| +246% | +$58.9K |
|
11932
PUT
Vir Biotechnology
VIR
$1.87B
| $76.6K | ﹤0.01% |
15,200
-119,500
| -89% | -$641K |
|
|
ICAD
11933
PUT
DELISTED
iCAD Inc
ICAD
| $76.6K | ﹤0.01% |
20,100
-17,600
| -47% | -$58.7K |
|
|
PGRE
11934
CALL
DELISTED
Paramount Group
PGRE
| $76.3K | ﹤0.01% |
+12,500
| New | +$65.1K |
|
11935
PUT
Fortress Biotech
FBIO
$93.7M
| $76.1K | ﹤0.01% |
40,900
+19,600
| +92% | +$33.9K |
|
11936
Ovid Therapeutics
OVID
$562M
| $76K | ﹤0.01% |
230,245
+147,161
| +177% | +$44.3K |
|
11937
PUT
Cadiz
CDZI
$341M
| $75.9K | ﹤0.01% |
25,400
-60,400
| -70% | -$174K |
|
|
LNAI
11938
Lunai Bioworks
LNAI
$10.9M
| $75.8K | ﹤0.01% |
3,279
+1,544
| +89% | +$43.1K |
|
|
SRG
11939
PUT
Seritage Growth Properties
SRG
$119M
| $75.8K | ﹤0.01% |
+24,600
| New | +$70.9K |
|
|
TEI
11940
Templeton Emerging Markets Income Fund
TEI
$322M
| $75.7K | ﹤0.01% |
+12,617
| New | +$69.4K |
|
11941
BioCardia
BCDA
$18M
| $75.7K | ﹤0.01% |
38,808
-21,141
| -35% | -$47K |
|
11942
PUT
Microbot Medical
MBOT
$102M
| $75.6K | ﹤0.01% |
30,000
+2,800
| +10% | +$6.7K |
|
|
TURN
11943
CALL
DELISTED
180 Degree Capital
TURN
| $75.4K | ﹤0.01% |
+19,000
| New | +$74.3K |
|
11944
TechPrecision Corp
TPCS
$57.9M
| $75.4K | ﹤0.01% |
20,216
+3,554
| +21% | +$11.2K |
|
|
HUIZ
11945
Huize Holding Ltd
HUIZ
$17.8M
| $75.2K | ﹤0.01% |
+35,986
| New | +$74.2K |
|
11946
TOMI Environmental Solutions
TOMZ
$14.1M
| $75.2K | ﹤0.01% |
23,640
+4,589
| +24% | +$12.3K |
|
11947
CALL
Village Farms International
VFF
$350M
| $75.1K | ﹤0.01% |
68,300
+53,300
| +355% | +$47.2K |
|
|
HURA
11948
TuHURA Biosciences
HURA
$136M
| $74.9K | ﹤0.01% |
33,599
+19,801
| +144% | +$66.9K |
|
11949
PUT
Blend Labs
BLND
$355M
| $74.9K | ﹤0.01% |
22,700
+5,800
| +34% | +$19.7K |
|
11950
CALL
CXApp
CXAI
$9.19M
| $74.9K | ﹤0.01% |
+1,400
| New | +$74K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.